The decrease in healthcare-associated methicillin-resistant Staphylococcus aureus infections and savings from glycopeptide use
Özet
We evaluated changes in the rate of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections and healthcare-associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000-2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased. © 2006 by The Society for Healthcare Epidemiology of America. All rights reserved.
